| Trial ID: | L5069 |
| Source ID: | NCT00521690
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Incidence of serious adverse events, including major hypoglycaemic events, during 16 weeks of insulin detemir therapy | Secondary: Change in HbA1C, after 16 weeks|Change in weight|Change in fasting plasma glucose (FPG)|Incidence of hypoglycaemic episodes
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-12
|
| Completion Date: |
2007-08
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-02
|
| Locations: |
Taipei, 100, Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT00521690
|
